Wednesday, October 03, 2018 6:39:32 AM
First of all, all of my blue dye posts are available for you to review at your own convenience. Second of all, it's not up to me to prove their drug is unsafe. It is up to them to prove their drug is safe, which they had not done, and that was the entire point of my presentation to FDA. There had not been one safety study that was ever done, despite the known toxicity of blue dye #1, despite the FDA Advisory about multiple deaths caused by blue dye #1, and despite that no drug (or any consumer product) has ever contained anywhere close to that amount of blue dye #1. If you truly want the answer to your question, call IPCI and ask them to do the safety studies that FDA now says are going to be required. (Unsuspecting oxy patients of the world: you're welcome.) Dr. Odidi is the one who decided not to try to prove the drug was safe, not me, and not the FDA.
And as for your previous question about how many lives would have been saved if it were approved, the answer is zero. There are already 2 approved formulations of 12 HR OXY ADF, including one that actually does prevent chewing abuse. Likewise, the best available data suggests ADF's do not save lives. More ADF prescriptions results in more street drug use which results in more heroin/fentanyl overdose deaths. Again, this information is all readily available in my previous posts and in about a thousand news reports. Feel free to read them and educate yourself at any time, but don't try to project your ignorance on to me.
Call on God but row away from the rocks.
-Hunter S. Thompson
Recent IPCI News
- Suspension de la négociation par l'Organisme canadien de réglementation des investissements - IPCI • PR Newswire (Canada) • 03/06/2024 12:55:00 PM
- Canadian Investment Regulatory Organization Trading Halt - IPCI • PR Newswire (Canada) • 03/06/2024 12:51:00 PM
DaBaby and Stunna 4 Vegas's "NO DRIBBLE" Joins Music Licensing, Inc.'s Portfolio • SONGD • Jun 7, 2024 10:15 AM
Mushrooms Inc. (OTC: MSRM) Announces Significant Share Buy Back by the Board Director and New Strategic Initiatives. • MSRM • Jun 5, 2024 1:32 PM
Hydromer Announces Launch of HydroThrombX Medical Device Coating Technology • HYDI • Jun 5, 2024 10:24 AM
Dr. Michael Dent Finances $1 Million to Drive HealthLynked's Healthcare Transformation • HLYK • Jun 5, 2024 8:00 AM
Avant Technologies Enters Binding LOI to Purchase Dozens of High-Performance, Immersible, AI-Powered Servers • AVAI • Jun 5, 2024 8:00 AM
IQST - iQSTEL Announces $290 Million 2024 Annual Revenue Forecast • IQST • Jun 4, 2024 1:43 PM